Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.

Nicholson SA, Okby NT, Khan MA, Welsh JA, McMenamin MG, Travis WD, Jett JR, Tazelaar HD, Trastek V, Pairolero PC, Corn PG, Herman JG, Liotta LA, Caporaso NE, Harris CC.

Cancer Res. 2001 Jul 15;61(14):5636-43.

2.

Wrapper arms strategy to construct multicomponent plasmids using three-piece ligation.

Hagiwara K, McMenamin MG.

Biotechniques. 2000 Jul;29(1):34-6. No abstract available.

3.

Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers.

Hagiwara K, McMenamin MG, Miura K, Harris CC.

Cancer Res. 1999 Sep 1;59(17):4165-9.

4.

Mutational analysis of p73 and p53 in human cancer cell lines.

Yoshikawa H, Nagashima M, Khan MA, McMenamin MG, Hagiwara K, Harris CC.

Oncogene. 1999 Jun 3;18(22):3415-21.

5.

Screening cloned PCR fragments by restriction endonuclease finger-printing to obtain wild-type sequences.

Hagiwara K, Freeman AA, McMenamin MG, Harris CC.

Biotechniques. 1998 Oct;25(4):554-5, 558. No abstract available.

6.

SV40-induced immortalization and ras-transformation of human bronchial epithelial cells.

Reddel RR, De Silva R, Duncan EL, Rogan EM, Whitaker NJ, Zahra DG, Ke Y, McMenamin MG, Gerwin BI, Harris CC.

Int J Cancer. 1995 Apr 10;61(2):199-205.

PMID:
7705948
7.

Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.

Ke Y, Reddel RR, Gerwin BI, Reddel HK, Somers AN, McMenamin MG, LaVeck MA, Stahel RA, Lechner JF, Harris CC.

Am J Pathol. 1989 May;134(5):979-91.

8.

Differential uptake of isomeric 2-bromohydroquinone-glutathione conjugates into kidney slices.

Lau SS, McMenamin MG, Monks TJ.

Biochem Biophys Res Commun. 1988 Apr 15;152(1):223-30.

PMID:
2895999
9.
10.

Metabolism of arachidonic acid in human lung cancer cell lines.

Lau SS, McMahon JB, McMenamin MG, Schuller HM, Boyd MR.

Cancer Res. 1987 Jul 15;47(14):3757-62.

11.
12.

2-Methylfuran toxicity in rats--role of metabolic activation in vivo.

Ravindranath V, McMenamin MG, Dees JH, Boyd MR.

Toxicol Appl Pharmacol. 1986 Aug;85(1):78-91.

PMID:
3726888
13.

Differential distribution and covalent binding of two labeled forms of methyl-CCNU in the Fischer 344 rat.

Kramer RA, McMenamin MG, Boyd MR.

Cancer Chemother Pharmacol. 1985;14(2):150-5.

PMID:
3971479
14.
15.

Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.

Fisher RI, Mandell GL, Bostick F, McMenamin MG, Anderson T.

Clin Exp Immunol. 1980 Feb;39(2):416-25.

16.
17.
18.

Streptozotocin diabetes--further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver.

Schein PS, Cooney DA, McMenamin MG, Anderson T.

Biochem Pharmacol. 1973 Oct 15;22(20):2625-31. No abstract available.

PMID:
4357891
19.

3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.

Schein PS, McMenamin MG, Anderson T.

Cancer Res. 1973 Sep;33(9):2005-9. No abstract available.

Supplemental Content

Loading ...
Support Center